MiR-145 inhibits the migration and invasion of papillary thyroid carcinoma cells through NF-κB pathway regulation

被引:13
|
作者
Chen, Gengyu [1 ]
Gao, Ying [2 ]
Wang, Gangpu [1 ]
Dai, Guofeng [1 ]
Li Tong [1 ]
机构
[1] Fourth Hosp Jinan City Jinan, Dept Gen Surg 2, 50 Shifan Rd, Jinan 250021, Shandong, Peoples R China
[2] Shandong Univ, Shandong Qianfoshan Hosp, Dept Lab Med, Jinan, Shandong, Peoples R China
关键词
invasion; migration; miR-145; NF-kappa B pathway; papillary thyroid carcinoma; MESENCHYMAL TRANSITION; CANCER STATISTICS; MICRORNA; GROWTH; PROLIFERATION; EXPRESSION; TARGETS;
D O I
10.1002/jcb.29604
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Papillary thyroid carcinoma (PTC) is the most prevalent cancer in the endocrine system, and the number of patients diagnosed with PTC has been increasing rapidly in recent years. Previous studies have reported that miR-145 plays an important role in many kinds of cancers, but its function in PTC remains unclear. In this study, we found that compared to paracancerous tissues, the level of miR-145 expression was significantly downregulated in PTC tissues. When miR-145 is overexpressed, migration and invasion of PTC cells were suppressed in vitro. In addition, we found that miR-145 downregulated the nuclear factor-kappa B (NF-kappa B) pathway in PTC cells. Taken together, our data suggest that miR-145 functions as a tumor suppressor in PTC with the suppressive effect related to downregulation of the NF-kappa B pathway.
引用
收藏
页码:3325 / 3332
页数:8
相关论文
共 50 条
  • [1] MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells
    Wu, Jing
    Yin, Li
    Jiang, Ning
    Guo, Wen-jie
    Gu, Jia-jia
    Chen, Meng
    Xia, You-you
    Wu, Jian-zhong
    Chen, Dan
    Wu, Jian-feng
    Wang, De-jun
    Zong, Dan
    Zhang, Nan
    Ding, Kai
    Huang, Teng
    He, Xia
    EXPERIMENTAL CELL RESEARCH, 2015, 338 (02) : 232 - 238
  • [2] Celastrol inhibits migration and invasion through blocking the NF-κB pathway in ovarian cancer cells
    Wang, Zhongye
    Zhai, Zhenyuan
    Du, Xiulan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (01) : 819 - 824
  • [3] miR-145 Inhibits Migration and Invasion of Glioma Stem Cells by Targeting ABCG2
    Shi, Lei
    Wang, Zhimin
    Sun, Guan
    Wan, Yi
    Guo, Jun
    Fu, Xingli
    NEUROMOLECULAR MEDICINE, 2014, 16 (02) : 517 - 528
  • [4] MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells
    Lu, Yong
    Chopp, Michael
    Zheng, Xuguang
    Katakowski, Mark
    Buller, Benjamin
    Jiang, Feng
    ONCOLOGY REPORTS, 2013, 29 (01) : 67 - 72
  • [5] Downregulation of lncRNA H19 inhibits migration and invasion of human osteosarcoma through the NF-κB pathway
    Zhao, Jun
    Ma, Shi-Tang
    MOLECULAR MEDICINE REPORTS, 2018, 17 (05) : 7388 - 7394
  • [6] MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2
    Xue, K. -C.
    Hu, D. -D.
    Zhao, L.
    Li, N.
    Shen, H. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (17) : 3794 - 3800
  • [7] RETRACTED: Lidocaine inhibits growth, migration and invasion of gastric carcinoma cells by up-regulation of miR-145 (Retracted Article)
    Sui, Hongyang
    Lou, Anfeng
    Li, Zhisong
    Yang, Jianjun
    BMC CANCER, 2019, 19 (1)
  • [8] MiR-381-3p inhibits proliferation, migration and invasion by targeting LRP6 in papillary thyroid carcinoma
    Kong, W.
    Yang, L.
    Li, P. -P.
    Kong, Q. -Q.
    Wang, H. -Y.
    Han, G. -X.
    Wang, Q. -B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (12) : 3804 - 3811
  • [9] ANKRD37 inhibits trophoblast migration and invasion by regulating the NF-κB pathway in preeclampsia
    Tan, Wang
    Fu, Huijia
    Zhou, Xiaobo
    Duan, Yuhan
    Yin, Nanlin
    Huang, Jiayu
    Liu, Xiru
    JOURNAL OF GENE MEDICINE, 2022, 24 (05)
  • [10] miR-145 Inhibits Migration and Invasion of Glioma Stem Cells by Targeting ABCG2
    Lei Shi
    Zhimin Wang
    Guan Sun
    Yi Wan
    Jun Guo
    Xingli Fu
    NeuroMolecular Medicine, 2014, 16 : 517 - 528